Add a beneficial impact on climate change to the long list of benefits being attributed to GLP-1 agonist medicines. An unusual study presented at the European Society of Cardiology (ESC) congress in ...

With competition in the GLP-1 category increasingly cutthroat, Novo Nordisk has latched onto a real-world study that found its weight-loss drug Wegovy was better than Eli Lilly's rival Zepbound at ...

Myocarditis is generally a mild and self-limited consequence of systemic infection of cardiotropic viruses. However, patients can develop a temporary or permanent impairment of cardiac function ...

Acute decompensated heart failure (ADHF) is one of the leading admission diagnoses worldwide, yet it is an entity with incompletely understood pathophysiology and limited therapeutic options. Patients ...

Digitoxin in addition to guideline-directed medical therapy, reduced the risk of a composite of all-cause death and hospitalization for worsening heart failure (HF) among patients with advanced HF and ...

Correspondence to Dr Patricia Campbell, Cardiology Department, Southern Health and Social Care Trust, Craigavon, UK; PatriciaM.Campbell{at}southerntrust.hscni.net To understand the definition and ...

Prophylactic ICD therapy did not reduce mortality in patients with a prior myocardial infarction (MI), persistent moderate left ventricular (LV) systolic dysfunction and abnormal ECG markers, ...